A Wall Street Journal op-ed claims the FDA is "attacking a safe, effective drug," Ivermectin, even though the FDA itself certified the medication in 1996.
A recent pre-print review based on peer-reviewed studies has found that using antiparasitic drug ivermectin could lead to “large reductions” in COVID-19 deaths and its use could have a “significant impact” on the pandemic globally.
A doctor from the Philippines is defending the use of ivermectin for preventing and treating Wuhan coronavirus (COVID-19) infection despite attempts by the country’s regulatory authorities to restrict its use. In an interview with Philippine television station ABS-CBN, orthopedic surgeon and President of the Concerned Doctors and Citizens of the Philippines, Dr. Benigno Agbayani cited 80 clinical studies that show the anti-parasitic drug is 89 percent effective at preventing infection and 80 percent effective at treating COVID-19.
A peer-reviewed study found that ivermectin can end the COVID pandemic. The medicine was found to “significantly reduces the risk of contracting the deadly respiratory disease when used regularly.”
